Henney AE, Riley DR, O’Connor B, et al. Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all-cause mortality in adults, compared with bisphosphonates: An analysis of real-world, cohort data, with a systematic review and meta-analysis. Diabetes Obes Metab. Published online June 20, 2024. doi:10.1111/dom.15708
Source link : https://www.medscape.com/s/viewarticle/denosumab-osteoporosis-may-prevent-type-2-diabetes-2024a1000c4r?src=rss
Author :
Publish date : 2024-07-02 13:00:00
Copyright for syndicated content belongs to the linked Source.